Prolacta Bioscience recognizes advances in preterm care during NICU awareness month
Type: Press Releases
Topic(s): Company
Prolacta Bioscience applauds Ohio legislature for supporting Medicaid reimbursement for donor human milk-derived products
Type: Press Releases
Topic(s): Legislative
New study shows Prolacta’s human milk-based nutritional fortifiers save hospital NICUs up to $3.4M annually
Type: Press Releases
Topic(s): Bronchopulmonary Dysplasia (BPD) Clinical Studies on Prolact/Humavant CR Cost Savings / Cost Effectiveness Length of hospital stay Necrotizing Entercolitis (NEC)
Study reveals Prolacta’s 100% human milk-based nutritional fortifiers significantly increase bioactive proteins and antioxidant activity in human milk samples, outperforming cow milk-based fortifier
Type: Press Releases
Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Company Growth Probiotics Product
Prolacta Bioscience celebrates donor moms on World Human Milk Donation Day
Type: Press Releases
Topic(s): Company Donors
Prolacta Bioscience recognizes contributions of breast milk donors during National Nutrition Month
Type: Press Releases
Topic(s): Company Parents
The Prolacta Bioscience Foundation empowers parents and communities with over half a million dollars in grant funding in 2022
Type: Press Releases
Topic(s): Company Parents
Hot Topics in Neonatology 2022 Conference will include symposium on benefits of vat pasteurization for human donor milk
Type: Press Releases
Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Company Conferences and Events Microbiome Probiotics
Prolacta Clinical Advisory Board members present webinar on improved growth metrics for preterm infants fed an exclusive human milk diet
Type: Press Releases
Topic(s): Feeding Protocols Growth
Not finding the reference you’re looking for?
Use our main search field or email us at info@prolacta.com
